Top

Journal of Cancer Research and Clinical Oncology

Published in:

01-03-2009 | Review

The possible involvement of virus in breast cancer

Authors: Marla Karine Amarante, Maria Angelica Ehara Watanabe

Published in: Journal of Cancer Research and Clinical Oncology | Issue 3/2009

Abstract

It is well known that the etiology of human breast cancer is significantly affected by environmental factors. Virus-associated cancer refers to a cancer where viral infection results in the malignant transformation of the host’s infected cells. Human papillomaviruses (HPV), mouse mammary tumor virus (MMTV) and Epstein–Barr (EBV) virus are prime candidate viruses as agents of human breast cancer. The precise role that viruses play in tumorigenesis is not clear, but it seems that they are responsible for causing only one in a series of steps required for cancer development. The idea that a virus could cause breast cancer has been investigated for quite some time, even though breast cancer could be a hereditary disease; however, hereditary breast cancer is estimated to account for a small percentage of all breast cancer cases. Based on current research, this review present at moment, substantial, but not conclusive, evidence that HPV, EBV and MMTV may be involved in breast cancer.

Acha-Orbea H, Shakhov AN, Finke D (2007) Immune response to MMTV infection. Front Biosci 12:1594–1609. doi:10.2741/2172 PubMedCrossRef

Akil N, Yasmeen A, Kassab A et al (2008) High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study. Br J Cancer 99(3):404–407. doi:10.1038/sj.bjc.6604503 PubMedCrossRef

Arbach H, Viglasky V, Lefeu F et al (2006) Epstein–Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol). J Virol 80:845–853. doi:10.1128/JVI.80.2.845-853.2006 PubMedCrossRef

Baseman JG, Koustsky LA (2005) The epidemiology of human papillomavirus infections. J Clin Virol 32:16–24. doi:10.1016/j.jcv.2004.12.008 CrossRef

Bindra A, Muradrasoli S, Kisekka R (2007) Search for DNA of exogenous mouse mammary tumor virus-related virus in human breast cancer samples. J Gen Virol 6:1806–1809. doi:10.1099/vir.0.82767-0 CrossRef

Bittner JJ (1936) Some possible effects of nursing on the mammary gland tumor incidence in mice. Science 84:162. doi:10.1126/science.84.2172.162 PubMedCrossRef

Bonnet M, Guinebretiere JM, Kremmer E et al (1999) Detection of Epstein–Barr virus in invasive breast cancers. J Natl Cancer Inst 91:1376–1381. doi:10.1093/jnci/91.16.1376 PubMedCrossRef

Bratthauer GL, Tavassoli FA, O’Leary TJ (1992) Etiology of breast carcinoma: no apparent role for papillomavirus types 6/11/16/18. Pathol Res Pract 188(3):384–386PubMed

Brink AA, van Den Brule AJ, van Diest P et al (2000) Re: detection of Epstein–Barr virus in invasive breast cancers. J Natl Cancer Inst 92:655–656. doi:10.1093/jnci/92.8.655 PubMedCrossRef

Choi YL, Cho EY, Kim JH et al (2007) Detection of human papillomavirus DNA by DNA chip in breast carcinomas of Korean women. Tumour Biol 28:327–332. doi:10.1159/000124238 PubMedCrossRef

Chu JS, Chen CC, Chang KJ (1998) In situ detection of Epstein–Barr virus in breast cancer. Cancer Lett 124:53–57. doi:10.1016/S0304-3835(97)00449-7 PubMedCrossRef

Chu PG, Chang KL, Chen YY et al (2001) No significant association of Epstein–Barr virus infection with invasive breast carcinoma. Am J Pathol 159:571–578PubMed

Dadmanesh F, Peterse JL, Sapino A et al (2001) Lymphoepithelioma-like carcinoma of the breast: lack of evidence of Epstein–Barr virus infection. Histopathology 38(1):54–61. doi:10.1046/j.1365-2559.2001.01055.x PubMedCrossRef

Damin AP, Karam R, Zettler CG et al (2004) Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat 84:131–137. doi:10.1023/B:BREA.0000018411.89667.0d PubMedCrossRef

de Cremoux P, Thioux M, Lebigot I et al (2008) No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat 109:55–58. doi:10.1007/s10549-007-9626-4 PubMedCrossRef

Deshpande CG, Badve S, Kidwai N et al (2002) Lack of expression of the Epstein–Barr virus (EBV) gene products, EBERs, EBNA1, LMP1, and LMP2A, in breast cancer cells. Lab Invest 82:1193–1199PubMed

de Villiers EM, Sandstrom RE, zur Hausen H et al (2005) Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res 7:01–11CrossRef

Di Lonardo A, Venuti A, Marcante ML (1992) Human papillomavirus in breast cancer. Breast Cancer Res Treat 21(2):95–100. doi:10.1007/BF01836955 PubMedCrossRef

Dimmock NJ, Primrose SB (1994) Carcinogenesis and tumour viruses. Introduction to modern virology, 4th edn. Blackwell Science, London

Etkind P, Du J, Khan A et al (2000) Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clin Cancer Res 6:1273–1278PubMed

Etkind PR, Stewart AF, Dorai T et al (2004) Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin’s lymphomas of individual patients diagnosed with both malignancies. Clin Cancer Res 10:5656–5664. doi:10.1158/1078-0432.CCR-03-0364 PubMedCrossRef

Etkind PR, Stewart AF, Wiernik PH (2008) Mouse mammary tumor virus (MMTV)-like DNA sequences in the breast tumors of father, mother, and daughter. Infect Agent Cancer 28(3):2

Fawzy S, Sallam M, Awad NM (2008) Detection of Epstein–Barr virus in breast carcinoma in Egyptian women. Clin Biochem 41:486–492PubMed

Fina F, Romain S, Ouafik L et al (2001) Frequency and genome load of Epstein–Barr virus in 509 breast cancers from different geographical areas. Br J Cancer 84:783–790. doi:10.1054/bjoc.2000.1672 PubMedCrossRef

Ford CE, Tran D, Deng Y et al (2003) Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women. Clin Cancer Res 9:1118–1120PubMed

Ford CE, Faedo M, Crouch R et al (2004a) Progression from normal breast pathology to breast cancer is associated with increasing prevalence of mouse mammary tumor virus-like sequences in men and women. Cancer Res 64:4755–4759. doi:10.1158/0008-5472.CAN-03-3804 PubMedCrossRef

Ford CE, Faedo M, Rawlinson WD (2004b) Mouse mammary tumor virus-like RNA transcripts and DNA are found in affected cells of human breast cancer. Clin Cancer Res 10:7284–7289. doi:10.1158/1078-0432.CCR-04-0767 PubMedCrossRef

Frank O, Verbeke C, Schwarz N et al (2008) Variable transcriptional activity of endogenous retroviruses in human breast cancer. J Virol 82:1808–1818. doi:10.1128/JVI.02115-07 PubMedCrossRef

Fukuoka H, Moriuchi M, Yano H et al (2008) No association of mouse mammary tumor virus-related retrovirus with Japanese cases of breast cancer. J Med Virol 80(8):1447–1451. doi:10.1002/jmv.21247 PubMedCrossRef

Gaffey MJ, Frierson HF Jr, Mills SE et al (1993) Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance. Mod Pathol 6:721–728PubMed

Glaser SL, Ambinder RF, DiGiuseppe JA et al (1998) Absence of Epstein–Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers. Int J Cancer 75:555–558. doi:10.1002/(SICI)1097-0215(19980209)75:4<555::AID-IJC10>3.0.CO;2-8PubMedCrossRef

Gopalkrishna V, Singh UR, Sodhani P et al (1996) Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat 39:197–202. doi:10.1007/BF01806186 PubMedCrossRef

Grinstein S, Preciado MV, Gattuso P et al (2002) Demonstration of Epstein–Barr virus in carcinomas of various sites. Cancer Res 62:4876–4878PubMed

Gumus M, Yumuk PF, Salepci T et al (2006) HPV DNA frequency and subset analysis in human breast cancer patients’ normal and tumoral tissue samples. J Exp Clin Cancer Res 25:515–521PubMed

Hachana M, Trimeche M, Ziadi S et al (2008) Prevalence and characteristics of the MMTV-like associated breast carcinomas in Tunisia. Cancer Lett 271(2):222–230. doi:10.1016/j.canlet.2008.06.001 PubMedCrossRef

Hennard C, Pfuhl T, Buettner M et al (2006) The antibody 2B4 directed against the Epstein–Barr virus (EBV)-encoded nuclear antigen 1 (EBNA1) detects MAGE-4: implications for studies on the EBV association of human cancers. J Pathol 209(4):430–435. doi:10.1002/path.1996 PubMedCrossRef

Hennig EM, Suo Z, Thoresen S et al (1999) Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat 53:121–135. doi:10.1023/A:1006162609420 PubMedCrossRef

Herrmann K, Niedobitek G (2003) Lack of evidence for an association of Epstein–Barr virus infection with breast carcinoma. Breast Cancer Res 5:R13–R17. doi:10.1186/bcr561 PubMedCrossRef

Horiuchi K, Mishima K, Ohsawa M et al (1994) Carcinoma of stomach and breast with lymphoid stroma: localisation of Epstein–Barr virus. J Clin Pathol 47:538–540. doi:10.1136/jcp.47.6.538 PubMedCrossRef

Ilvan S, Celik V, Ulker Akyildiz E et al (2004) Lymphoepithelioma-like carcinoma of the breast: is it a distinct entity? Clinicopathological evaluation of two cases and review of the literature. Breast 13(6):522–526PubMed

Indik S, Günzburg WH, Salmons B et al (2005) Mouse mammary tumor virus infects human cells. Cancer Res 65(15):6651–6659. doi:10.1158/0008-5472.CAN-04-2609 PubMedCrossRef

Indik S, Günzburg WH, Kulich P et al (2007) Rapid spread of mouse mammary tumor virus in cultured human breast cells. Retrovirology 4:73. doi:10.1186/1742-4690-4-73 PubMedCrossRef

Kalkan A, Ozdarendeli A, Bulut Y et al (2005) Investigation of Epstein–Barr virus DNA in formalin-fixed and paraffin-embedded breast cancer tissues. Med Princ Pract 14:268–271. doi:10.1159/000085748 PubMedCrossRef

Kan CY, Iacopetta BJ, Lawson JS et al (2005) Identification of human papillomavirus DNA gene sequences in human breast cancer. Br J Cancer 93:946–948. doi:10.1038/sj.bjc.6602778 PubMedCrossRef

Khan NA, Castillo A, Koriyama C et al (2008) Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer 99:408–414. doi:10.1038/sj.bjc.6604502 PubMedCrossRef

Kijima Y, Hokita S, Takao S et al (2001) Epstein–Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms. J Med Virol 64:513–518. doi:10.1002/jmv.1079 PubMedCrossRef

Kleer CG, Tseng MD, Gutsch DE et al (2002) Detection of Epstein–Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts. Mod Pathol 15:759–764. doi:10.1038/modpathol.3880602 PubMedCrossRef

Kordon EC (2008) MMTV-induced pregnancy-dependent mammary tumors: early history and new perspectives. J Mammary Gland Biol Neoplasia 13(3):289–297. doi:10.1007/s10911-008-9091-7 PubMedCrossRef

Kroupis C, Markou A, Vourlidis N et al (2006) Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem 39:727–731. doi:10.1016/j.clinbiochem.2006.03.005 PubMedCrossRef

Kulka J, Kovalszky I, Svastics E et al (2008) Lymphoepithelioma-like carcinoma of the breast: not Epstein–Barr virus—, but human papilloma virus—positive. Hum Pathol 39:298–301. doi:10.1016/j.humpath.2007.08.006 PubMedCrossRef

Kurose A, Ichinohasama R, Kanno H et al (2005) Lymphoepithelioma-like carcinoma of the breast. Report of a case with the first electron microscopic study and review of the literature. Virchows Arch 447:653–659. doi:10.1007/s00428-004-1195-x PubMedCrossRef

Labrecque LG, Barnes DM, Fentiman IS et al (1995) Epstein–Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res 55:39–45PubMed

Lau SK, Chen YY, Berry GJ et al (2003) Epstein–Barr virus infection is not associated with fibroadenomas of the breast in immunosuppressed patients after organ transplantation. Mod Pathol 16:1242–1247. doi:10.1097/01.MP.0000097363.72401.00 PubMedCrossRef

Lawson JS, Günzburg WH, Whitaker NJ (2006a) Viruses and human breast cancer. Future Microbiol 1:33–51. doi:10.2217/17460913.1.1.33 PubMedCrossRef

Lawson JS, Tran DD, Carpenter E et al (2006b) Presence of mouse mammary tumour-like virus gene sequences may be associated with morphology of specific human breast cancer. J Clin Pathol 59(12):1287–1292. doi:10.1136/jcp.2005.035907 PubMedCrossRef

Lespagnard L, Cochaux P, Larsimont D et al (1995) Absence of Epstein–Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction. Am J Clin Pathol 103:449–452PubMed

Levine PH, Pogo BG, Klouj A et al (2004) Increasing evidence for a human breast carcinoma virus with geographic differences. Cancer 101:721–726. doi:10.1002/cncr.20436 PubMedCrossRef

Li T, Lu ZM, Guo M et al (2002) p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer 95:2571–2576. doi:10.1002/cncr.11008 PubMedCrossRef

Lin JH, Tsai CH, Chu JS et al (2007) Dysregulation of HER2/HER3 signaling axis in Epstein–Barr virus-infected breast carcinoma cells. J Virol 81:5705–5713. doi:10.1128/JVI.00076-07 PubMedCrossRef

Lindel K, Forster A, Altermatt HJ et al (2007) Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast 16:172–177. doi:10.1016/j.breast.2006.09.001 PubMedCrossRef

Liu Y, Klimberg VS, Andrews NR et al (2001) Human papillomavirus DNA is present in a subset of unselected breast cancers. J Hum Virol 4:329–334PubMed

Luqmani YA, Shousha S (1995) Presence of Epstein–Barr virus in breast carcinoma. Int J Oncol 6:899–903

Magrath I, Bhatia K (1999) Breast cancer: a new Epstein–Barr virus-associated disease? J Natl Cancer Inst 91:1349–1350. doi:10.1093/jnci/91.16.1349 PubMedCrossRef

Mant C, Cason J (2004) A human murine mammary tumour virus-like agent is an unconvincing etiological agent for human breast cancer. Cancer Res 61:1754–1759

McCall SA, Lichy JH, Bijwaard KE et al (2001) Epstein–Barr virus detection in ductal carcinoma of the breast. J Natl Cancer Inst 93:148–150. doi:10.1093/jnci/93.2.148 PubMedCrossRef

Melana SM, Holland JF, Pogo BG (2001) Search for mouse mammary tumor virus-like env sequences in cancer and normal breast from the same individuals. Clin Cancer Res 7:283–284PubMed

Melana SM, Nepomnaschy I, Sakalian M et al (2007) Characterization of viral particles isolated from primary cultures of human breast cancer cells. Cancer Res 67:8960–8965. doi:10.1158/0008-5472.CAN-06-3892 PubMedCrossRef

Melana SM, Picconi MA, Rossi C et al (2002) Detection of murine mammary tumor virus (MMTV) env gene-like sequences in breast cancer from Argentine patients. Medicina (B Aires) 62:323–327

Mendizabal-Ruiz AP, Morales JA, Ramírez-Jirano LJ et al (2008) Low frequency of human papillomavirus DNA in breast cancer tissue. Breast Cancer Res Treat 30. Epub ahead of print

Mok MT, Lawson JS, Iacopetta BJ et al (2008) Mouse mammary tumor virus-like env sequences in human breast cancer. Int J Cancer 122:2864–2870. doi:10.1002/ijc.23372 PubMedCrossRef

Murono S, Inoue H, Tanabe T et al (2001) Induction of cyclooxygenase-2 by Epstein–Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci USA 98:6905–6910. doi:10.1073/pnas.121016998 PubMedCrossRef

Murray PG, Lissauer D, Junying J et al (2003) Reactivity with a monoclonal antibody to Epstein–Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome. Cancer Res 63:2338–2343PubMed

Perkins RS, Sahm K, Marando C et al (2006) Analysis of Epstein–Barr virus reservoirs in paired blood and breast cancer primary biopsy specimens by real time PCR. Breast Cancer Res 8(6):R70. doi:10.1186/bcr1627 PubMedCrossRef

Perrigoue JG, den Boon JA, Friedl A et al (2005) Lack of association between EBV and breast carcinoma. Cancer Epidemiol Biomarkers Prev 14:809–811. doi:10.1158/1055-9965.EPI-04-0763 PubMedCrossRef

Preciado MV, Chabay PA, De Matteo EN et al (2005) Epstein–Barr virus in breast carcinoma in Argentina. Arch Pathol Lab Med 129:377–381PubMed

Ribeiro-Silva A (2005) Epstein–Barr virus in breast carcinoma in Argentina. Arch Pathol Lab Med 129(9):1088PubMed

Ross SR (2008) MMTV infectious cycle and the contribution of virus-encoded proteins to transformation of mammary tissue. J Mammary Gland Biol Neoplasia 13:299–307. doi:10.1007/s10911-008-9090-8 PubMedCrossRef

Sanati S, Ayala AG, Middleton LP (2004) Lymphoepithelioma-like carcinoma of the breast: report of a case mimicking lymphoma. Ann Diagn Pathol 8:309–315. doi:10.1016/j.anndiagpath.2004.07.012 PubMedCrossRef

Sarkar NH (1980) Type B virus and human breast cancer. In: The role of viruses in human cancer, vol 1. Elsevier, North Holland. pp 207–235

Schiffman M, Kjaer SK (2003) Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 31:14–19PubMed

Smith JS, Lindsay L, Hoots B et al (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121:621–632. doi:10.1002/ijc.22527 PubMedCrossRef

Szabo S, Haislip AM, Garry RF (2005) Of mice, cats, and men: is human breast cancer a zoonosis? Microsc Res Tech 68:197–208. doi:10.1002/jemt.20232 PubMedCrossRef

Thorne LB, Ryan JL, Elmore SH et al (2005) Real-time PCR measures Epstein–Barr Virus DNA in archival breast adenocarcinomas. Diagn Mol Pathol 14:29–33. doi:10.1097/01.pas.0000144448.23464.ab PubMedCrossRef

Trabelsi A, Rammeh S, Stita W et al (2008) Detection of Epstein–Barr virus in breast cancers with lymphoid stroma. Ann Biol Clin (Paris) 66:59–62

Tsai JH, Tsai CH, Cheng MH et al (2005) Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol 75:276–278. doi:10.1002/jmv.20267 PubMedCrossRef

Wakisaka N, Pagano JS (2003) Epstein–Barr virus induces invasion and metastasis factors. Anticancer Res 23:2133–2138PubMed

Wakisaka N, Murono S, Yoshizaki T et al (2002) Epstein-Barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2. Cancer Res 62:6337–6344

Wang Y, Holland JF, Bleiweiss IJ et al (1995) Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res 55:5173–5179PubMed

Wang Y, Go V, Holland JF et al (1998) Expression of mouse mammary tumor virus-like env gene sequences in human breast cancer. Clin Cancer Res 4:2565–2568PubMed

Wang Y, Melana SM, Baker B et al (2003) High prevalence of MMTV-like env gene sequences in gestational breast cancer. Med Oncol 20:233–236. doi:10.1385/MO:20:3:233 PubMedCrossRef

Wang Y, Jiang JD, Xu D et al (2004) A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer. Cancer Res 64:4105–4111. doi:10.1158/0008-5472.CAN-03-3880 PubMedCrossRef

Widschwendter A, Brunhuber T, Wiedemair A et al (2004) Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol 31:292–297. doi:10.1016/j.jcv.2004.06.009 PubMedCrossRef

Witt A, Hartmann B, Marton E et al (2003) The mouse mammary tumor virus-like env gene sequence is not detectable in breast cancer tissue of Austrian patients. Oncol Rep 10:1025–1029PubMed

Wong M, Pagano JS, Schiller JT et al (2002) New associations of human papillomavirus, Simian virus 40, and Epstein–Barr virus with human cancer. J Natl Cancer Inst 94:1832–18336PubMed

Wrede D, Luqmani YA, Coombes RC et al (1992) Absence of HPV 16 and 18 DNA in breast cancer. Br J Cancer 65:891–894PubMed

Xue SA, Lampert IA, Haldane JS et al (2003) Epstein–Barr virus gene expression in human breast cancer: protagonist or passenger? Br J Cancer 89:113–119. doi:10.1038/sj.bjc.6601027 PubMedCrossRef

Yasmeen A, Bismar TA, Dekhil H et al (2007) ErbB-2 receptor cooperates with E6/E7 oncoproteins of HPV type 16 in breast tumorigenesis. Cell Cycle 6:2939–2943PubMed

Yasui Y, Potter JD, Stanford JL et al (2001) Breast cancer risk and “delayed” primary Epstein–Barr virus infection. Cancer Epidemiol Biomarkers Prev 10:9–16PubMed

Yu Y, Morimoto T, Sasa M et al (1999) HPV33 DNA in premalignant and malignant breast lesions in Chinese and Japanese populations. Anticancer Res 19:5057–5061PubMed

Zammarchi F, Pistello M, Piersigilli A et al (2006) MMTV-like sequences in human breast cancer: a fluorescent PCR/laser microdissection approach. J Pathol 209:436–444. doi:10.1002/path.1997 PubMedCrossRef

Zangen R, Harden S, Cohen D et al (2002) Mouse mammary tumor-like env gene as a molecular marker for breast cancer? Int J Cancer 102:304–307. doi:10.1002/ijc.10702 PubMedCrossRef

Zapata-Benavides P, Saavedra-Alonso S, Zamora-Avila D et al (2007) Mouse mammary tumor virus-like gene sequences in breast cancer samples of Mexican women. Intervirology 50:402–407. doi:10.1159/000110652 PubMedCrossRef

Title: The possible involvement of virus in breast cancer
Authors: Marla Karine Amarante
Maria Angelica Ehara Watanabe
Publication date: 01-03-2009
Publisher: Springer-Verlag
Published in: Journal of Cancer Research and Clinical Oncology / Issue 3/2009
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-008-0511-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2009

Association of loss of BRCA1 expression with centrosome aberration in human breast cancer

Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling

Galectin-3 in urine of cancer patients: stage and tissue specificity

Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin’s lymphoma

Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection

The correlation of genetic instability of PINX1 gene to clinico-pathological features of gastric cancer in the Chinese population

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage